Search Clinical Trials

Search results for Neurology.

Found 54 clinical studies.

• Foretell

  • Investigator: Michael Privitera
  • Posted Date: Sep 26, 2025
  • Type of Study: Observational/Survey

• A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study With An Open-Label Extension Period To Evaluate The Efficacy And Safety Of Telitacicept In Patients With Generalized Myasthenia Gravis

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 11, 2025
  • Type of Study: Drug

• A Phase 2, Randomized, Double-Blinded, Placebo-Controlled, Study To Evaluate Safety, Tolerability, Pharmacometrics, And Efficacy Of Dnth103 In Adults With Multifocal Motor Neuropathy (Momentum)

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 11, 2025
  • Type of Study: Drug

• A Phase 3, Double-Blind, Placebo-Controlled Study Evaluating Efficacy And Safety Of Riliprubart In Participants With Refractory Chronic Inflammatory Demyelinating Polyneuropathy

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 11, 2025
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blind, Study Evaluating Efficacy And Safety Of Riliprubart Versus Intravenous Immunoglobulin (Ivig) In Participants With Chronic Inflammatory Demyelinating Polyneuropathy

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 11, 2025
  • Type of Study: Drug

• A Phase 3, Randomized, Double-Blinded, Double-Dummy Study Evaluating The Efficacy And Safety Of Empasiprubart Versus Intravenous Immunoglobulin In Adults With Multifocal Motor Neuropathy

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 10, 2025
  • Type of Study: Drug

• A Randomized, Double-Blind, Placebo-Controlled Phase III Study To Evaluate The Efficacy, Safety, And Tolerability Of Remibrutinib In Patients With Generalized Myasthenia Gravis, Followed By An Open-Label Extension Phase

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 10, 2025
  • Type of Study: Drug

• A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Dnth103 In Adults With Chronic Inflammatory Demyelinating Polyneuropathy (Captivate)

  • Investigator: Hani Kushlaf
  • Posted Date: Sep 10, 2025
  • Type of Study: Drug

• A35-009 Orion

  • Investigator: Luca Marsili
  • Posted Date: Jul 14, 2025
  • Type of Study: Drug

• An Integrative Computational Multimodal Approach To Disentangle Pathophysiologic Heterogeneity Of Age-Related White Matter Hyperintensities

  • Investigator: Matthew Flaherty
  • Posted Date: Jul 11, 2025
  • Type of Study: Observational/Survey

• Video-Based Smartphone-Assisted Bradykinesia Assessment In Parkinson’S Disease

  • Investigator: Luca Marsili
  • Posted Date: May 9, 2025
  • Type of Study: Observational/Survey

• A Phase 2, Randomized, Double-Blind, Four-Arm, Placebo-Controlled, Multicenter Study Assessing The Efficacy, Safety And Tolerability Of Three Doses Of Orally Administered Bms-986368, A Faah/Mgll Inhibitor, For The Treatment Of Spasticity In Participants W

  • Investigator: Shahla Hosseini
  • Posted Date: Apr 30, 2025
  • Type of Study: Drug

• Phase III Trial Of Single Fraction Stereotactic Radiosurgery (Srs) Versus Fractionated Srs (Fsrs) For Intact Brain Metastases

  • Investigator: Kyle Wang
  • Posted Date: Apr 28, 2025
  • Type of Study: Observational/Survey

• A Study Of Car T-Cell Therapy And Its Effects On Handwriting And Coordination

  • Investigator: Luca Marsili
  • Posted Date: Mar 10, 2025
  • Type of Study: Observational/Survey

• A Phase 2, Randomized, Double-Blind, Placebo-Controlled Parallel Group Study Of Vhb937 In Amyotrophic Lateral Sclerosis (Als) Over 40 Weeks Followed By An Open-Label Extension (Astrals)

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2025
  • Type of Study: Drug

• A Post-Authorization Study To Assess Long-Term Safety In Patients With Pompe Disease Treated With Avalglucosidase Alfa

  • Investigator: Hani Kushlaf
  • Posted Date: Mar 5, 2025
  • Type of Study: Observational/Survey

• Librexia-Stroke

  • Investigator: Matthew Flaherty
  • Posted Date: Feb 19, 2025
  • Type of Study: Drug

• Optimizing Cns Dha Delivery In Elderly Adults At Risk For Dementia

  • Investigator: Robert Mcnamara
  • Posted Date: Jan 7, 2025
  • Type of Study: Drug

• A Phase 3 Randomized, Double-Blind, Placebo- Controlled, Global Study To Evaluate The Efficacy And Safety Of Intravenous Aoc 1001 For The Treatment Of Myotonic Dystrophy Type 1

  • Investigator: Hani Kushlaf
  • Posted Date: Nov 7, 2024
  • Type of Study: Drug

• Representative Utility Values For The Modified Rankin (Ruler)

  • Investigator: Paul Wechsler
  • Posted Date: Jun 3, 2024
  • Type of Study: Observational/Survey

• Efficacy, Safety And Tolerability Of Bhv-7000 In Subjects With Refractory Focal Onset Epilepsy- Rise 2

  • Investigator: Michael Privitera
  • Posted Date: Apr 24, 2024
  • Type of Study: Drug

• A Novel Wearable System For Monitoring And Alerting For Seizures And Cardiorespiratory Dysfunctions

  • Investigator: Michael Privitera
  • Posted Date: Apr 24, 2024
  • Type of Study: Device

• Repeated Assessment Of Survivors In Intracerebral Hemorrhage Study (Reassess Ich)

  • Investigator: Matthew Flaherty
  • Posted Date: Apr 22, 2024
  • Type of Study: Observational/Survey

• Self-Reported Mental Health In Adults With Cerebral Palsy

  • Investigator: Jensine Clark
  • Posted Date: Apr 19, 2024
  • Type of Study: Observational/Survey

• Cancer Related Cognitive Impairment (Crci) And Its Relationship To Specific Types Of Changes In Thinking And Other Medical Conditions

  • Investigator: Rhonna Shatz
  • Posted Date: Apr 18, 2024
  • Type of Study: Observational/Survey

• Biomarkers Of Disease Progression In Progressive Supranuclear Palsy

  • Investigator: Alberto Espay
  • Posted Date: Mar 13, 2023
  • Type of Study: Observational/Survey

• Development And Validation Of The Unified Tremor Rating Scale (Utrs)

  • Investigator: Luca Marsili
  • Posted Date: Oct 18, 2022
  • Type of Study: Observational/Survey

• Sofia Aspiration System As The First Line Technique

  • Investigator: Charles Prestigiacomo
  • Posted Date: Oct 18, 2022
  • Type of Study: Device

• Patterns Of Social Media Use By Autistic Communities

  • Investigator: Al Lutwak
  • Posted Date: Aug 30, 2022
  • Type of Study: Observational/Survey

• Effects Of Lingual Endurance Exercise On Rehabilitation Of Swallowing Impairment After

  • Investigator: Brittany Krekeler
  • Posted Date: Aug 11, 2022
  • Type of Study: Device

• The Helping Children With Loss Instrument (Hcwl-I): Instrument Development And Validation For Construct Validity Of The Treatment

  • Investigator: Rachael Nolan
  • Posted Date: Jul 28, 2022
  • Type of Study: Observational/Survey

• The Influence Of Popular Media On Biases Of Potential Care Providers Toward Nonspeaking Autistic People

  • Investigator: Al Lutwak
  • Posted Date: Jul 25, 2022
  • Type of Study: Observational/Survey

• Healthy Aging And Alzheimer's Disease In Epilepsy

  • Investigator: Russell Sawyer
  • Posted Date: Apr 25, 2022
  • Type of Study: Observational/Survey

• Phase 1/2, Two-Part, Open-Label Dose-Escalation And Double-Blind, Placebo-Controlled Dose-Expansion Study With An Open-Label Extension To Evaluate The Safety And Efficacy Of Ata188 In Subjects With Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Jun 22, 2021
  • Type of Study: Drug

• Trial Of Parkinson’S And Zoledronic Acid

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Drug

• Ppmi 2.0 Clinical -Establishing A Deeply Phenotyped Pd Cohort

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• The Dystonia Coalition Natural History And Biospecimen Repository For Isolated Dystonias (Dcp)

  • Investigator: Abhimanyu Mahajan
  • Posted Date: Apr 30, 2021
  • Type of Study: Observational/Survey

• A Dose Selection Trial Of Light Therapy For Impaired Sleep In Parkinson’S Disease

  • Investigator: Alberto Espay
  • Posted Date: Apr 30, 2021
  • Type of Study: Device

• An Open-Label, Multicenter Phase 4 Study To Assess Disease Activity And Biomarkers Of Neuronal Damage In Minority Patients With Relapsing Multiple Sclerosis Receiving Treatment With Ocrelizumab

  • Investigator: Lawrence Goldstick
  • Posted Date: Mar 19, 2021
  • Type of Study: Drug

• Bn42083 A Phase IIIb Multicenter, Randomized, Double-Blind, Controlled Study To Evaluate The Efficacy, Safety And Pharmacokinetics Of A Higher Dose Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Feb 15, 2021
  • Type of Study: Drug

• Effects Of Plasma Exchange On Adolescent And Adult Patients With Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections (Pandas)

  • Investigator: Caroline Alquist
  • Posted Date: Jan 21, 2021
  • Type of Study: Observational/Survey

• Gn42272: A Phase III Randomized, Double-Blind Study To Evaluate Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Patients With Relapsing Multiple Sclerosis

  • Investigator: Aram Zabeti
  • Posted Date: Oct 23, 2020
  • Type of Study: Drug

• Optimizing Training In Severe Post-Stroke Walking Impairment

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Quantifying The Role Of Sensory Systems Processing In Post-Stroke Walking Recovery

  • Investigator: Oluwole Awosika
  • Posted Date: Sep 22, 2020
  • Type of Study: Observational/Survey

• Study In Parkinson's Disease Of Exercise Phase 3 Clinical Trial: Sparx3

  • Investigator: Alberto Espay
  • Posted Date: Sep 14, 2020
  • Type of Study: Observational/Survey

• Erich-Gene

  • Investigator: Stacie Demel
  • Posted Date: Aug 25, 2020
  • Type of Study: Observational/Survey

• Ehr-Embedded Decision Support To Prevent Stroke In Patients With Af

  • Investigator: Mark Eckman
  • Posted Date: Apr 1, 2020
  • Type of Study: Observational/Survey

• Cincinnati Cohort Biomarkers Program

  • Investigator: Alberto Espay
  • Posted Date: Mar 16, 2020
  • Type of Study: Observational/Survey

• Fviia For Acute Hemorrhagic Stroke Administered At Earliest Time (Fastest) Trial

  • Investigator: Kyle Walsh
  • Posted Date: Mar 9, 2020
  • Type of Study: Drug

• Neuroscience Retrospective Chart Review

  • Investigator: Eva Mistry
  • Posted Date: Jan 23, 2020
  • Type of Study: Observational/Survey

• Is Hypotension The Mechanism Behind Cognitive Fluctuations In Parkinson’S Disease Dementia And Dementia With Lewy Bodies?

  • Investigator: Abhimanyu Mahajan
  • Posted Date: Oct 29, 2019
  • Type of Study: Observational/Survey

• A Study To Evaluate The Safety And Effectiveness Of A New Antiseizure Drug Called Xen1101

  • Investigator: Brian Moseley
  • Posted Date: Jun 12, 2019
  • Type of Study: Drug

• Optimizing Magnetic Resonance Imaging Acquisitions For Brain Imaging

  • Investigator: Jinghua Wang
  • Posted Date: Jun 6, 2019
  • Type of Study: Device

• Epidemiology Of Subdural Hematomas At The University Of Cincinnati Medical Center

  • Investigator: David Robinson
  • Posted Date: May 22, 2019
  • Type of Study: Observational/Survey